Abstract: Use of indocyanine green (ICG) in a pump-probe scheme for OCT is proposed. The study illustrates that ICG in protein solution shows unusual pump-probe imaging potential, indicating its usefulness as a contrast agent for OCT.
Introduction
Optical coherence tomography [1] (OCT) is an excellent technique for high resolution imaging of biological samples to a depth of few millimeters. Various approaches such as Doppler [2] and birefringence [3] have been adopted to add to the functionality of OCT. Recent developments of a new OCT imaging modality known as molecular contrast optical coherence tomography (MCOCT) [4, 5] 
Molecular Contrast Optical Coherence Tomography Setup
The spectral domain fiber-optic MCOCT setup, shown Fig. 3(a) , uses two 2x2 fiber couplers. Light from a modelocked Ti:sapphire (12 nm FWHM) is coupled into a standard 5/125 pm single mode fiber (SMF) for spectrum broadening. The broadband probe light (45 nm FWH4M centered at 780 nm) from the SMF fiber is coupled into the first coupler via a fiber-optic attenuator (FOA) to control the amount of light reaching the sample. One of the output ports of the first fiber coupler is connected to an optical spectrum analyzer to monitor the spectrum of the source whereas the other is connected to the second fiber coupler. The other input port ofthe second coupler is connected to a fiber-coupled pump laser operating at 806.25 nm. The output arms of the second coupler make the reference and sample arms. A 1mm path length cuvette filled with 200 jM ICG-NaI solution in 1% albumin is used as the sample. The polarization controller (PC) in the sample arm corrects for the birefringence artifacts in the sample and/or reference arms. Light from the reference and sample is collected back via the same optics and detected by Ocean Optics, Inc. fiber-coupled spectrometer (HR4000) connected to the input port of the first fiber-coupler. A personal computer (PC) is used to both control the pump laser as well as acquire data from the spectrometer. In conclusion, we have shown for the first time that ICG-Nal, when mixed in a protein solution such as albumin or human plasma, can be used as a contrast agent in pump-probe scheme for molecular contrast OCT of biological samples. The demonstrated MCOCT scheme generates a difference image, revealing the distribution of ICG-NaI within the sample, from pairs of consecutive A-scans acquired before and after the pump wavelength illumination.
